|Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification|
BD Cheson, RI Fisher, SF Barrington, F Cavalli, LH Schwartz, E Zucca, ...
Journal of clinical oncology 32 (27), 3059, 2014
|FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0|
R Boellaard, R Delgado-Bolton, WJG Oyen, F Giammarile, K Tatsch, ...
European journal of nuclear medicine and molecular imaging 42 (2), 328-354, 2015
|Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group|
SF Barrington, NG Mikhaeel, L Kostakoglu, M Meignan, M Hutchings, ...
Journal of clinical oncology 32 (27), 3048, 2014
|Imaging biomarker roadmap for cancer studies|
JPB O'Connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
|Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma|
J Radford, T Illidge, N Counsell, B Hancock, R Pettengell, P Johnson, ...
New England Journal of Medicine 372 (17), 1598-1607, 2015
|Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma|
P Johnson, M Federico, A Kirkwood, A Fosså, L Berkahn, A Carella, ...
N Engl J Med 374, 2419-2429, 2016
|Detection of lymphoma in bone marrow by whole-body positron emission tomography|
R Carr, SF Barrington, B Madan, MJ O'Doherty, CAB Saunders, ...
Blood, The Journal of the American Society of Hematology 91 (9), 3340-3346, 1998
|Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma|
SF Barrington, W Qian, EJ Somer, A Franceschetto, B Bagni, E Brun, ...
European journal of nuclear medicine and molecular imaging 37 (10), 1824-1833, 2010
|Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy|
BD Cheson, S Ansell, L Schwartz, LI Gordon, R Advani, HA Jacene, ...
Blood, The Journal of the American Society of Hematology 128 (21), 2489-2496, 2016
|International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers|
A Biggi, A Gallamini, S Chauvie, M Hutchings, L Kostakoglu, M Gregianin, ...
Journal of Nuclear Medicine 54 (5), 683-690, 2013
|The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale|
A Gallamini, SF Barrington, A Biggi, S Chauvie, L Kostakoglu, ...
Haematologica 99 (6), 1107, 2014
|PET scanning and the human immunodeficiency virus-positive patient|
M O'Doherty, SF Barrington, M Campbell, J Lowe, CS Bradbeer
Journal of Nuclear Medicine 38 (10), 1575-1583, 1997
|PET/CT for therapy response assessment in lymphoma|
M Hutchings, SF Barrington
Journal of nuclear medicine 50 (Suppl 1), 21S-30S, 2009
|Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam|
SF Barrington, MN Maisey
Journal of Nuclear Medicine 37 (7), 1127-1129, 1996
|Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography|
G Morton, A Chiribiri, M Ishida, ST Hussain, A Schuster, A Indermuehle, ...
Journal of the American College of Cardiology 60 (16), 1546-1555, 2012
|PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement|
AB Khan, SF Barrington, NG Mikhaeel, AA Hunt, L Cameron, T Morris, ...
Blood, The Journal of the American Society of Hematology 122 (1), 61-67, 2013
|Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology|
J Stauss, C Franzius, T Pfluger, KU Juergens, L Biassoni, J Begent, ...
European journal of nuclear medicine and molecular imaging 35 (8), 1581-1588, 2008
|FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas|
SF Barrington, R Kluge
European journal of nuclear medicine and molecular imaging 44 (1), 97-110, 2017
|Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL|
NG Mikhaeel, D Smith, JT Dunn, M Phillips, H Møller, PA Fields, ...
European journal of nuclear medicine and molecular imaging 43 (7), 1209-1219, 2016
|Early chemotherapy intensification with BEACOPP in advanced‐stage Hodgkin lymphoma patients with a interim‐PET positive after two ABVD courses|
A Gallamini, C Patti, S Viviani, A Rossi, F Fiore, F Di Raimondo, ...
British journal of haematology 152 (5), 551-560, 2011